Improved Tet-responsive promoters with minimized background expression

Background expression from a tet-responsive promoter has four separable sources, and only one of them is a property of the promoter sequence itself: residual transactivator binding to the operators in the off-state, long-range action of enhancers or other elements near the integration site, accessibility set by epigenetic parameters such as DNA methylation and chromatin, and intrinsic activity from cryptic transcription factor binding sites within the promoter. The first can be identified by comparing isogenic transactivator-positive and transactivator-negative cells, and the second can be avoided by targeted integration into a suitable locus or suppressed with insulator elements — leaving intrinsic promoter background as the part addressable by redesign.

Redesigning only the tet operator array of a tet-responsive promoter improves both halves of its dynamic range. Ptet-T1 differs from the original Ptet-1 solely in its operator heptamer — 36 nt centre-to-centre operator spacing instead of 42 nt, with randomized rather than identical spacer sequences between operators — yet gives 5-fold higher induced expression and 6-fold lower non-induced background in transiently transfected HeLa-EM2 cells, raising the regulation factor from about 400-fold to at least 13,000-fold.

Randomizing the spacer sequences between tet operators minimizes symmetry within the operator array, which matters for viral delivery: palindromic sequences are vulnerable during the strand displacement mechanism of reverse transcription and can cause gradual loss of operators from retroviral vectors.

Shortening the CMV leader sequence in a tet-responsive promoter is what removes most of its intrinsic background. Deleting the CMV 5′-UTR to leave a truncated downstream promoter element (Ptet-T3) or only the CMV initiator element directly followed by the start codon (Ptet-T4) reduces off-state background more than 30-fold relative to Ptet-1, while induced expression stays high.

Replacing the CMV 5′-UTR of a tet-responsive promoter with an unrelated plant viral sequence lowers background further, because that sequence carries few cis-elements active in animal cells. A leader from turnip yellow mosaic virus fused 3′ of the CMV initiator, with its RFX-1 and AP-4 binding sites removed by point mutation, gives Ptet-T5; further variants Ptet-T6 and Ptet-T7 additionally remove potential splice signals (changing 5′-AGGT-3′ to 5′-AGCT-3′) and hairpin structures that could confer cap-independent translation initiation.

Ptet-T6 is the best of the redesigned tet-responsive promoters, combining the randomized 36 nt operator array, consensus TATA-box and TFIIB recognition element, CMV initiator and modified turnip yellow mosaic virus 5′-UTR. In transient transfection it shows background more than 100-fold below Ptet-1 and about 10-fold below Ptet-14 (Ptight), giving a regulation factor near 50,000-fold against 400-fold for Ptet-1 and 6,200-fold for Ptet-14, while its induced expression still slightly exceeds Ptet-1's.

Which promoter modification matters depends on whether the construct is episomal or chromosomally integrated. After γ-retroviral transduction of HtTA-1 cells at low multiplicity of infection so most cells carry a single integrated copy, the ranking of off-state background across the redesigned Ptet promoters matches the transient transfection results and Ptet-T6 again gives the lowest background — but introducing the consensus TFIIB recognition element (the only change from Ptet-T1 to Ptet-T2) suppresses background far more strongly after chromosomal integration than in transient assays.

Rebuilding the tet-responsive promoter lowers background without changing how the system reads doxycycline. In HeLa-EM2 cells transduced with retroviral SIN vectors, Ptet-T6 background is 15-fold below Ptet-1 with slightly higher induced expression, together giving roughly a 30-fold wider regulation range, yet both promoters reach maximum induction at 300 ng/mL doxycycline with no further gain above that, and both show the same steep rise between 10 and 100 ng/mL — indicating an identical synergistic response to increasing operator occupancy by the transactivator.

A low-background tet-responsive promoter allows transgene expression to be held at chosen intermediate levels even in genetically heterogeneous, non-clonal cell pools. MDA-MB231.ro cells expressing the rtTA-S2 transactivator, transduced with a retroviral SIN vector carrying erbB2 under Ptet-T6, show no recognizable off-state erbB2 at the cell surface, can be titrated with doxycycline to intermediate expression, and hold a chosen level for at least 14 days. Individual cells within such a pool behave remarkably similarly, and cell-to-cell variability falls further after prolonged growth at intermediate doxycycline.

Single-cell analysis of induction reveals heterogeneity that population averages hide: at partial induction with 30 ng/mL doxycycline every cell in a transduced population responds, but expression levels differ widely between individual cells. Isolating clones from a Ptet-T6 population both suppresses residual background in the vast majority of cells and markedly improves the precision of partial induction, which matters where a homogeneous intermediate expression level is required, such as analyzing pharmacological responses to varying cell-surface receptor density.

Sustained maximal expression from a tet-responsive promoter can select against the cells expressing most strongly. Under prolonged full induction at 1000 ng/mL doxycycline, MDA-MB231.ro cells carrying Ptet-T6-driven erbB2 lose the highest-expressing cells, seen as an asymmetric steep drop in the right shoulder of the expression profile — so the observed plateau reflects the maximum erbB2 level those cells tolerate long-term rather than the promoter's ceiling.